MEDICAL PROPERTIES TRUST INC(MPT)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,871 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
MPT Stock Analysis & AI Quality Score
AI stock analysis and institutional research for MEDICAL PROPERTIES TRUST INC (MPT), a Real Estate sector company. 13F Pro's AI-powered ranking engine scores MPT at 42.0/100 on a 32-signal composite quality model, placing it at rank #1,871 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include profitability (14.1) and earnings quality (30.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 36.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), MEDICAL PROPERTIES TRUST INC reports quarterly revenue of $252.1M, net income of $32.8M, free cash flow of $-14.3M. Top institutional holders of MPT by reported 13-F value include BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, STATE STREET, based on the most recent SEC filings. MPT trades on the NYSE exchange and files with the SEC under CIK 1287865. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MPT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MEDICAL PROPERTIES TRUST INC directly from SEC EDGAR. MEDICAL PROPERTIES TRUST INC's 13F Pro composite quality score has ranged between 31 and 42 since 2026, currently 42.0 — an improving long-term trajectory across 10 quarterly and live scoring snapshots.
Revenue
Q1 2026
$252.1M
Net Income
Q1 2026
$32.8M
Free Cash Flow
Q1 2026
$-14.3M
ROIC
Q1 2026
0.0%
D/E Ratio
Q1 2026
2.13
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
-35.5% YoYNet Income
-367.0% YoYOperating Income
EPS (Diluted)
-368.0% YoYTotal Assets
-27.3% YoYTotal Debt
-13.8% YoYOp. Cash Flow
-66.8% YoY| Metric | FY 2024 | FY 2022 | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Revenue | $995.5M -35.5% | $1.54B -0.1% | $1.54B +23.6% | $1.25B +77.3% | $704.7M +30.2% | $541.1M |
| Net Income | $-2.41B -367.0% | $902.6M +37.6% | $656.0M +52.1% | $431.4M +48.9% | $289.8M +28.8% | $225.0M |
| Operating Income | — | — | — | — | $485.6M +42.1% | $341.6M |
| EPS (Diluted) | $-4.02 -368.0% | $1.50 +35.1% | $1.11 +37.0% | $0.81 -1.2% | $0.82 -4.7% | $0.86 |
| Total Assets | $14.29B -27.3% | $19.66B -4.2% | $20.52B +21.9% | $16.83B +86.6% | $9.02B +40.5% | $6.42B |
| Total Debt | $8.85B -13.8% | $10.27B -9.0% | $11.28B +27.3% | $8.87B +81.0% | $4.90B +68.4% | $2.91B |
| Operating Cash Flow | $245.5M -66.8% | $739.0M -9.0% | $811.7M +31.4% | $617.6M +70.5% | $362.2M +37.3% | $263.8M |
Get alerted when MPT's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for MEDICAL PROPERTIES TRUST INC including:
Top Institutional Holders of MPT
BlackRock, Inc.
$348.6M75,297,881 shVANGUARD PORTFOLIO MANAGEMENT LLC
$199.5M43,084,764 shSTATE STREET CORP
$120.7M25,561,209 shVANGUARD CAPITAL MANAGEMENT LLC
$96.5M20,835,567 shCHARLES SCHWAB INVESTMENT MANAGEMENT INC
$55.5M11,980,733 shAQR CAPITAL MANAGEMENT LLC
$51.2M11,057,099 shGEODE CAPITAL MANAGEMENT, LLC
$46.2M9,981,922 shTWO SIGMA INVESTMENTS, LP
$38.9M8,400,722 shDIMENSIONAL FUND ADVISORS LP
$34.4M7,437,426 shWILSEY ASSET MANAGEMENT INC
$34.0M7,348,752 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $348.6M | 75,297,881 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $199.5M | 43,084,764 |
| STATE STREET CORP | $120.7M | 25,561,209 |
| VANGUARD CAPITAL MANAGEMENT LLC | $96.5M | 20,835,567 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $55.5M | 11,980,733 |
| AQR CAPITAL MANAGEMENT LLC | $51.2M | 11,057,099 |
| GEODE CAPITAL MANAGEMENT, LLC | $46.2M | 9,981,922 |
| TWO SIGMA INVESTMENTS, LP | $38.9M | 8,400,722 |
| DIMENSIONAL FUND ADVISORS LP | $34.4M | 7,437,426 |
| WILSEY ASSET MANAGEMENT INC | $34.0M | 7,348,752 |
More Real Estate Companies
View all Real Estate →Put MPT on your watchlist
Track score changes the day MEDICAL PROPERTIES TRUST INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is MPT a good stock to buy?
13F Pro's AI-powered analysis of MEDICAL PROPERTIES TRUST INC (MPT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Real Estate sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MPT are available on the MPT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own MPT?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MPT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of MEDICAL PROPERTIES TRUST INC's investment landscape.